Diabetes News Archive

Mice in lab tests showed signs of the first stages of this type of diabetes: their pancreas pumped out more insulin, while their muscles showed a delayed sensitivity to insulin. "When it's secreted, it's activating two different brain regions," Chen said. One region is related to your anxiety and fear level... and on the other hand will activate a region that is more related to metabolism." And ...

Migration from rural to urban areas is associated with increasing levels of obesity and is a factor driving the diabetes epidemic in India, according to a new study.

WASHINGTON, May 3 (Reuters) - The U.S. Food and Drug Administration is examining if certain hormone treatments for men with prostate cancer pose a greater risk of diabetes or heart problems than other therapies. The FDA is looking at data from published studies to determine the risks with commonly used Gonadotropin-Releasing Hormone (GnRH) agonist drugs, the agency said on Monday.

The U.S. Food and Drug Administration is examining if certain hormone treatments for men with prostate cancer pose a greater risk of diabetes or heart problems than other therapies.

Preliminary Data Suggests Group of Prostate Drugs Increases Risk of Diabetes, Heart Disease

WASHINGTON, May 3 (Reuters) - The U.S. Food and Drug Administration is examining if certain hormone treatments for men with prostate cancer pose a greater risk of diabetes or heart problems than other therapies. The FDA is looking at data from published studies to determine the risks with commonly used Gonadotropin-Releasing Hormone (GnRH) agonist drugs, the agency said on Monday.

The Food and Drug Administration is looking into data suggesting a group of prostate cancer drugs increase the risk of diabetes and heart disease. Food and Drug Administration - Prostate cancer - Heart disease - Health - Cancer

The Food and Drug Administration is examining if certain hormone treatments for men with prostate cancer pose a greater risk of diabetes or heart problems than other therapies.

The Food and Drug Administration is looking into data suggesting a group of prostate cancer drugs increase the risk of diabetes and heart disease. The drugs are used to suppress the hormone testosterone, which fuels the growth of prostate cancer tumors.... Food and Drug Administration - Prostate cancer - Cancer - Health - Conditions and Diseases

FDA warns that early evidence shows links between prostate cancer drugs and diabetes

FDA warns that early evidence shows links between prostate cancer drugs and diabetes Prostate cancer - Food and Drug Administration - Cancer - Health - Conditions and Diseases

The Food and Drug Administration is looking into data suggesting a group of prostate cancer drugs increase the risk of diabetes and heart disease.

WASHINGTON, May 3 (Reuters) - The U.S. Food and Drug Administration is examining whether certain hormone treatments for men with prostate cancer pose greater risk for diabetes or heart trouble. The FDA is looking at data from published studies to determine the risks with commonly used Gonadotropin-Releasing Hormone (GnRH) agonist drugs, the agency said on Monday.

The U.S. Food and Drug Administration is examining whether certain hormone treatments for men with prostate cancer pose greater risk for diabetes or heart trouble.

DOVER On May 8, the Eternal Embrace Hope Foundation and punk band Electric Mummy present the Beat Diabetes Benefit, an afternoon of music, prizes and inspirational presentations in support of diabetes awareness.

A research team led by Mayo Clinic physicians has found that older women with diabetes face a more than doubled risk for some types of colorectal cancer. The findings are being presented at Digestive Disease Week 2010, the annual meeting of the American Gastroenterological Association. Colorectal cancer remains the third-leading cause of cancer deaths among women in the United States. Diabetes ...

The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes...

The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.

An all-in-one mobile solution for on-the-go diabetes management available at Apple App Store

More than 350 walkers representing local corporations, families, schools and other organizations are expected to participate in the fourth annual Fond du Lac Community Juvenile Diabetes Research Foundation (JDRF) Walk to Cure Diabetes.

A research team led by Mayo Clinic physicians has found that older women with diabetes face a more than doubled risk for some types of colorectal cancer.